Cytodyn Inc (CYDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 05-2020 | 05-2019 | 05-2018 | 05-2017 | 05-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -139,936 | -56,187 | -50,150 | -25,764 | -25,704 |
| Depreciation Amortization | 4,083 | 3,411 | 2,458 | 366 | 2,853 |
| Income taxes - deferred | N/A | -2,827 | N/A | 0 | N/A |
| Accounts receivable | 91 | -91 | N/A | N/A | N/A |
| Other Working Capital | -1,593 | 1,186 | 14,622 | -988 | -6,278 |
| Other Operating Activity | 68,551 | 4,042 | 3,172 | -347 | 4,318 |
| Operating Cash Flow | $-68,804 | $-50,466 | $-29,898 | $-26,733 | $-24,811 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -41 | -26 | N/A | -11 | -12 |
| Purchase Sale Intangibles | N/A | -19 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -19 | 0 | 0 | 0 |
| Investing Cash Flow | $-41 | $-45 | $N/A | $-11 | $-12 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 15,000 | 14,877 | 4,889 | 1,150 | N/A |
| Common Stock Issued | 56,690 | 38,269 | 28,385 | 19,532 | 38,119 |
| Common Stock Repurchased | -8 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 7,988 | -399 | -3,920 | -1,804 | -4,704 |
| Financing Cash Flow | $79,670 | $52,747 | $29,354 | $18,877 | $33,414 |
| Beginning Cash Position | 3,467 | 1,231 | 1,776 | 9,642 | 1,050 |
| End Cash Position | 14,292 | 3,467 | 1,231 | 1,776 | 9,642 |
| Net Cash Flow | $10,825 | $2,236 | $-544 | $-7,866 | $8,592 |
| Free Cash Flow | |||||
| Operating Cash Flow | -68,804 | -50,466 | -29,898 | -26,733 | -24,811 |
| Capital Expenditure | -41 | -26 | N/A | -11 | -12 |
| Free Cash Flow | -68,845 | -50,492 | -29,898 | -26,744 | -24,823 |